Novartis reveals new drug to fight malaria resistance and transmission

Novartis reveals new drug to fight malaria resistance and transmission
Novartis reveals new drug to fight malaria resistance and transmission

Swiss pharmaceutical giant Novartis has unveiled a next-generation malaria treatment that not only demonstrates a 97% cure rate but also blocks disease transmission, representing a potential breakthrough in combating drug-resistant strains of the deadly parasite.

Read more